Clinical Trials are an essential step in the careful and controlled evaluation of new diagnostic tests and treatments. They typically examine both safety and effectiveness. Without these trials, physicians are unable to derive the data that ultimately fosters the best in patient care. They also offer patients who enroll the most modern cutting edge care, under intensive scrutiny and close observation. Patients choose to participate in clinical trials for many reasons; they may have the opportunity to receive treatments with tremendous promise but which are unavailable outside of a trial, or some simply appreciate the intrinsic feeling of contributing to the advancement of science.
The Clinical Trials Department at the Dean McGee Eye Institute has a wide range of studies, mostly funded by grants from the National Eye Institute/National Institutes of Health (NEI/NIH) and the pharmaceutical industry. Currently we are conducting clinical research in the sub-specialties of Glaucoma, Retina, Cornea, Pediatric Ophthalmology, and Neuro-Ophthalmology.
We hope you'll read further to learn more about our studies. We invite you to contact the the Clinial Trials department if you have a patient who might qualify for one of the following studies listed below.